Page last updated: 2024-09-03

sc 51089 and enkephalin, leucine

sc 51089 has been researched along with enkephalin, leucine in 1 studies

Compound Research Comparison

Studies
(sc 51089)
Trials
(sc 51089)
Recent Studies (post-2010)
(sc 51089)
Studies
(enkephalin, leucine)
Trials
(enkephalin, leucine)
Recent Studies (post-2010) (enkephalin, leucine)
4111911,52480754

Protein Interaction Comparison

ProteinTaxonomysc 51089 (IC50)enkephalin, leucine (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.0142
Kappa-type opioid receptorMus musculus (house mouse)0.0417
Mu-type opioid receptorHomo sapiens (human)9.5
Mu-type opioid receptorMus musculus (house mouse)0.0308
Mu-type opioid receptorCavia porcellus (domestic guinea pig)0.246

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Green, PG; Ho, T; Khasar, SG; Levine, JD1

Other Studies

1 other study(ies) available for sc 51089 and enkephalin, leucine

ArticleYear
Comparison of prostaglandin E1- and prostaglandin E2-induced hyperalgesia in the rat.
    Neuroscience, 1994, Volume: 62, Issue:2

    Topics: Alprostadil; Analgesics; Animals; Diabetes Mellitus, Experimental; Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide; Dinoprostone; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Hindlimb; Hydrazines; Hyperalgesia; Male; Oxazepines; Pain; Rats; Rats, Sprague-Dawley

1994